▼ -29.03% Downside Potential
This price target is based on 17 analysts offering 12 month price targets for Livongo Health in the last 3 months. The average price target is $98.65, with a high forecast of $170.00 and a low forecast of $41.00. The average price target represents a -29.03% upside from the last price of $139.00.
The current consensus among 17 contributing investment analysts is to buy stock in Livongo Health.
Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.